The Clinilabs team is comprised of industry leaders and experts in the field of clinical research. This team brings the best combination of scientific and operational experience to every project we run.
Gary Zammit, PhD - President and Chief Executive Officer
Gary Zammit, is the President & CEO of Clinilabs Drug Development Corporation, a full-service CRO that provides clinical drug development to industry, focusing on CNS therapeutics. Gary Zammit is a scientist and former academician who founded Clinilabs Drug Development Corporation in 2001, having the belief that there was an industry need for a specialty CNS CRO that could improve the way new drugs and medical devices are developed. Dr. Zammit is widely sought for his expertise in neuropsychiatric drug development. Gary has authored more than 230 original publications and 2 books, and has served as a reviewer and editor for well-known medical journals. He is committed to ensuring that Clinilabs Drug Development Corporation’s senior management remains involved in every project that we accept, so that clients have easy and immediate access to the leadership of a high-performance development team.
Eileen McAuley - Chief Operating Officer
Eileen McAuley has more than 25 years of clinical research experience, having occupied positions in operational and strategic leadership roles. She currently oversees Clinilabs Drug Development Corporation’s operations, and is responsible for the oversight of project management, monitoring services, data management, biostatistics, medical writing and our Phase 1 clinics. Most recently, Eileen served as Senior Vice President, Clinical Services, at Frontage Labs, a provider of Phase 1 clinical research and bioanalytic services. Prior to that, she was the COO at Integrium, a full service CRO for cardiovascular, metabolic, and dermatology trials.
Eileen began her career as a critical care nurse and progressed to serve in clinical operations roles of increasing responsibility, including roles as Director of Project Management and head of operations for specialty clinical organizations. She earned a master’s degree in public administration from Seton Hall University, with a focus on health policy and management. She received a Bachelor’s of science degree from Montclair State College in New Jersey.
Jerry Deptuch - Chief Information Officer
Jerry Deptuch is a seasoned Information Technology professional having achieved positions with increasing responsibility throughout his career. Jerry is committed to help set and lead the technology strategies of our organization in collaboration with the executive management team. With his hands-on approach, Jerry serves as an effective liaison between the technology department and the other business units within Clinilabs. Jerry is innovative in his approach to identify new technologies that can assist the organization in achieving its goals and objectives. Having a master’s degree in Mathematics, Jerry has a cost-effective approach in his methodologies to identify the resources needed to meet or exceed these goals and objectives.
As the Chief Information Officer, Jerry guides his team to create business value through technology, planning of business growth opportunities, and ensuring tech systems and procedures are in place to meet objectives while maintaining business efficiency and productivity at Clinilabs.
Berrin Önbas-Uzun - Vice President, Quality and Regulatory Compliance
Ms. Berrin Önbas-Uzun has more than 25 years of experience in quality management. Berrin graduated from Rutgers University with a degree in Analytical Chemistry. She started her career as an analytical chemist at Zenith Laboratories, where she supported the development of an analytical research laboratory. Her career later moved on to transdermal and ophthalmic formulations at Paco Research before she transitioned into a quality compliance position at Roberts Pharmaceuticals Corporation. Berrin designed and implemented a vendor qualification program, a quality manual, and quality systems at Roberts Pharmaceutical Corporation, which lead to her promotion to the head of quality systems. For nine years before joining Clinilabs, Berrin managed GMP compliance for drugs manufactured by the Pharmaceutical Development group of Bristol-Myers Squibb. She has designed a quality manual for Clinilabs, leads the Quality and Regulatory Compliance Department, and maintains our organization in audit/inspection ready status. Berrin brings a wealth of GXP knowledge and high level of quality oversight to every Clinilabs project.
Nancy Cameron, MA - Vice President of Clinical Operations
Ms. Nancy Cameron has worked in the clinical research industry for over 25 years. She obtained her BS degree in Radiologic Science from the University of North Carolina at Chapel Hill and has a MA in Educational Administration. Nancy has proven abilities in the monitoring and management of Phase I to Phase IV Clinical Trials across a broad range of therapeutic areas, with an emphasis in central nervous system (CNS) drug development. Her CNS experience has spanned from small, complex Phase 1 and II studies to Phase 3 global trials in Alzheimer’s disease, mild cognitive impairment, Parkinson’s disease, Multiple System Atrophy, Multiple Sclerosis, Attention Deficit Disorder, sleep, analgesia, and CNS rare diseases within adult, geriatric, and pediatric populations. Nancy began her clinical research career as a Clinical Research Associate. After five years of clinical monitoring, she moved to project management and has progressed to increasing roles of responsibilities. At Clinilabs as Vice President of Clinical Operations, Nancy oversees and supports a specialty CNS group of project managers, monitors, and other study team members to ensure timely delivery and quality
Jeanine M. Falinski (Estrada), MBA - Vice President, Marketing and Communications
Ms. Jeanine Falinski (Estrada), Vice President of Marketing and Communications, has more than 15 years of experience in the pharmaceutical industry. Jeanine graduated from Emerson College with a degree in New Media and Marketing. She, later on, received her MBA in Pharmaceutical Management from the LeBow College of Business at Drexel University. Jeanine joined Clinilabs in 2004 as a Manager of Subject Recruitment and continued on through positions of progressive responsibility including Senior Director of Marketing and Communications and Senior Director of Business Development. In 2014, she joined Evolution Research Group as Senior Director of Business Development. Later on, she joined Artcraft Health, a marketing agency devoted to patient engagement and recruitment in clinical trials. In January of 2019, Jeanine returned to Clinilabs having gained valuable experience in other organizations and is excited to bring a new level of strategy and design to our team and our clients.
Allison House - Vice President of Clinical Operations
Ms. Allison House has over 17 years of experience in clinical trials project management experience, as well as 5 years of experience in clinical monitoring and trial coordination. Allison obtained the Bachelor of Sciences degree in Biological Sciences from North Carolina State University, and began working in clinical research shortly thereafter. She has extensive experience across a broad range of therapeutic areas, with an emphasis in central nervous system (CNS) drug development. In addition to her focus on sleep therapeutics, Allison has experience managing single-center, multicenter, and global multicenter clinical trials in Alzheimer’s disease, mild cognitive impairment, schizophrenia, bipolar disorder, major depression, Parkinson’s disease, multiple sclerosis, attention deficit disorder, addiction (opioid), smoking cessation, and analgesia. Allison has dealt with the unique challenges of first in human studies, orphan indications, and late phase global development programs. She currently oversees a specialty CNS group of project managers, monitors, and other study team members.
Maha Ahmad, MD, MMSc - Medical Director
Dr. Maha Ahmad obtained the Bachelor of Science degree (ScB) in Neuroscience from Brown University in Providence, Rhode Island. She went on to obtain a Master of Medical Science (MMSc) degree, as well as a Doctor of Medicine (MD) degree, also from Brown University, graduating in 2001. Maha completed residency training in psychiatry and completed a fellowship in child and adolescent psychiatry at the New York Presbyterian Hospital, Weill Cornell Medical Center in New York. She went on to do a sleep medicine fellowship at the Sleep Disorders Institute. Thereafter, Maha was hired as an attending physician at the Sleep Disorders Institute, where she became involved in clinical research. She is board certified in psychiatry and sleep medicine. Maha has been a valued member of the Clinilabs Drug Development Corporation team since 2007, and has served as a PI, Sub-I, and medical advisor in numerous CNS clinical trials managed by the company.
Amy McCoy, MD, MS - Vice President, Data Services
Dr. Amy McCoy received the Doctor of Medicine degree from Beijing Second Medical College (Beijing, China) and completed her training in Internal Medicine at Xuanwu Hospital in Beijing. Amy also completed her MS in Medical Research at Capital University of Medical Science (Beijing, China). She went on to hold the position of Physician and Assistant Research Professor, Department Cardiology and Hypertension Laboratory at Wuanwu Hospital in Beijing. Amy also holds a Master’s of Science in Computer Sciences from Brooklyn College (CUNY), majoring in Information Management.
Amy has worked in various capacities at Clinilabs since 2004. As the Vice President of Data Services, she is responsible for overseeing multi-center clinical trial data management. With over 15 years of medical, clinical trial, and information management experience, Amy has helped to serve the diverse needs of our customers. She has developed special expertise in electronic data management, including CNS test data collected in clinical trials.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
– George W. Merck